卒中后抑郁的血清生物标志物  

Serum biomarkers of post-stroke depression

作　　者：张子良 陈金波[1] 宋晓文[1] 苏毅鹏[1] 李斌[1] Zhang Ziliang;Chen Jinbo;Song Xiaowen;Su Yipeng;Li Bin(Department of Neurology, Binzhou Medical University Hospital, Binzhou 256603, Chin)

机构地区：[1]滨州医学院附属医院神经内科,256600

出　　处：《国际脑血管病杂志》2018年第3期207-212,共6页International Journal of Cerebrovascular Diseases

摘　　要：卒中后抑郁（post-stroke depression,PSD）是卒中后最常见的精神障碍性疾病,以心境障碍为主要表现形式.临床调查显示,PSD患病率高达30％～50％,严重影响患者生活和工作,给个人、家庭以及整个社会都带来严重的影响和沉重的经济负担.PSD血清生物标志物的发现为其诊断和治疗提供了新方向.文章对PSD的血清生物标志物进行综述. Post-stroke depression （PSD） is the most common psychiatric disorder after stroke,and mood disorders are the main manifestations.Clinical investigation shows that the prevalence of PSD is as high as 30%-50%.It seriously affects the lives and work of patients,and brings serious impact and heavy economic burden on individuals,families,and the entire society.The discovery of serum biomarkers of PSD has provided a new direction for its diagnosis and treatment.This article reviews the serum biomarker of PSD.

关 键 词：卒中 抑郁症 生物标志物 

分 类 号：R743.3[医药卫生—神经病学与精神病学] R749.4[医药卫生—临床医学]